PubRank

G E Ranges

Author PubWeight™ 26.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 1985 2.92
2 Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J Immunol 1991 2.52
3 Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1. J Immunol 1988 1.84
4 Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol 1989 1.40
5 Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol 1988 1.26
6 The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction. J Immunol 1988 1.20
7 Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. J Leukoc Biol 1993 1.15
8 1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorg Med Chem Lett 2000 1.14
9 Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 1995 1.12
10 T cell development in normal and thymopentin-treated nude mice. J Exp Med 1982 1.06
11 Effect of cytotoxic monoclonal antibody depletion of T-lymphocyte subpopulations on bleomycin-induced lung damage in C57BL/6J mice. Toxicol Appl Pharmacol 1989 0.92
12 Genomic cloning and heterologous expression of human differentiation-stimulating factor. DNA 1989 0.91
13 Alteration of bronchoalveolar lavage cell populations following bleomycin treatment in mice. Toxicol Appl Pharmacol 1989 0.91
14 Genetic control of tolerance induction to human gamma-globulin in mice. J Immunol 1978 0.88
15 In vivo immunomodulation by monoclonal anti-L3T4. 1. Effects on humoral and cell-mediated immune response. Cell Immunol 1987 0.88
16 Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J Immunol 1990 0.87
17 Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B. J Immunol 1994 0.83
18 Discovery of a new class of p38 kinase inhibitors. Bioorg Med Chem Lett 2000 0.83
19 Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibody. Eur J Immunol 1992 0.80
20 Suppression of T cell cytotoxicity by nude mouse spleen cells: reversal by monosaccharides and interleukin 2. J Immunol 1983 0.78
21 Immunotherapy of autoimmune disease with T cell subset specific antibodies. Concepts Immunopathol 1987 0.77
22 Development of T-cell function in relation to T-cell set diversification in nu/nu mice. Cell Immunol 1986 0.77
23 A synthetic mycobacterial heat shock peptide prevents adjuvant arthritis but not proteoglycan-induced synovitis in the rat. Agents Actions 1991 0.76
24 p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas. Bioorg Med Chem Lett 2001 0.75
25 Chromosome assignments of the human TNF p55 and p75 receptor genes. J Exp Zool 1992 0.75
26 Interleukin-2 and aging: decreased interleukin-2 production in healthy older people does not correlate with reduced helper cell numbers or antibody response to influenza vaccine and is not corrected in vitro by thymosin alpha 1. Immunopharmacology 1985 0.75
27 Functional relationships of Lyt-2 and Lyt-3 expression and T-cell cytotoxicity: a new model system. Adv Exp Med Biol 1985 0.75
28 Inheritance of tolerance susceptibility to human gamma-globulin in congenic mice. J Immunol 1979 0.75